These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18954041)

  • 41. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
    Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
    J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening multicomponent reactions for X-linked inhibitor of apoptosis-baculoviral inhibitor of apoptosis protein repeats domain binder.
    Monfardini I; Huang JW; Beck B; Cellitti JF; Pellecchia M; Dömling A
    J Med Chem; 2011 Feb; 54(3):890-900. PubMed ID: 21241056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
    Metwalli AR; Khanbolooki S; Jinesh G; Sundi D; Shah JB; Shrader M; Choi W; Lashinger LM; Chunduru S; McConkey DJ; McKinlay M; Kamat AM
    Cancer Biol Ther; 2010 Nov; 10(9):885-92. PubMed ID: 20814238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, in silico evaluation, and in vitro verification of new bivalent Smac mimetics with pro-apoptotic activity.
    Huang Q; Peng Y; Peng Y; Lin H; Deng S; Feng S; Wei Y
    Methods; 2024 Apr; 224():35-46. PubMed ID: 38373678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner.
    Probst BL; Liu L; Ramesh V; Li L; Sun H; Minna JD; Wang L
    Cell Death Differ; 2010 Oct; 17(10):1645-54. PubMed ID: 20431601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of a heterodimeric Smac-based peptide that features sequences specific to both the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
    Speer KF; Cosimini CL; Splan KE
    Biopolymers; 2012; 98(2):122-30. PubMed ID: 22020922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.
    Oost TK; Sun C; Armstrong RC; Al-Assaad AS; Betz SF; Deckwerth TL; Ding H; Elmore SW; Meadows RP; Olejniczak ET; Oleksijew A; Oltersdorf T; Rosenberg SH; Shoemaker AR; Tomaselli KJ; Zou H; Fesik SW
    J Med Chem; 2004 Aug; 47(18):4417-26. PubMed ID: 15317454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid-conjugated Smac analogues.
    Micewicz ED; Ratikan JA; Waring AJ; Whitelegge JP; McBride WH; Ruchala P
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4419-27. PubMed ID: 26384289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biophysical characterization of the interaction between the full-length XIAP and Smac/DIABLO.
    Polykretis P; Luchinat E
    Biochem Biophys Res Commun; 2021 Sep; 568():180-185. PubMed ID: 34247143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of aminopiperidine-based Smac mimetics as IAP antagonists.
    Hennessy EJ; Saeh JC; Sha L; MacIntyre T; Wang H; Larsen NA; Aquila BM; Ferguson AD; Laing NM; Omer CA
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1690-4. PubMed ID: 22264476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
    Bockbrader KM; Tan M; Sun Y
    Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP.
    Lu J; Bai L; Sun H; Nikolovska-Coleska Z; McEachern D; Qiu S; Miller RS; Yi H; Shangary S; Sun Y; Meagher JL; Stuckey JA; Wang S
    Cancer Res; 2008 Nov; 68(22):9384-93. PubMed ID: 19010913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic.
    Sun H; Nikolovska-Coleska Z; Lu J; Qiu S; Yang CY; Gao W; Meagher J; Stuckey J; Wang S
    J Med Chem; 2006 Dec; 49(26):7916-20. PubMed ID: 17181177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAP.
    Ardecky RJ; Welsh K; Finlay D; Lee PS; González-López M; Ganji SR; Ravanan P; Mace PD; Riedl SJ; Vuori K; Reed JC; Cosford ND
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4253-7. PubMed ID: 23743278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Importance of ligand reorganization free energy in protein-ligand binding-affinity prediction.
    Yang CY; Sun H; Chen J; Nikolovska-Coleska Z; Wang S
    J Am Chem Soc; 2009 Sep; 131(38):13709-21. PubMed ID: 19736924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation.
    Hamacher-Brady A; Brady NR
    J Biol Chem; 2015 Sep; 290(36):22005-18. PubMed ID: 26134559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The activator of apoptosis Smac-DIABLO acts as a tetramer in solution.
    Mastrangelo E; Vachette P; Cossu F; Malvezzi F; Bolognesi M; Milani M
    Biophys J; 2015 Feb; 108(3):714-23. PubMed ID: 25650938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dimerization of Smac is crucial for its mitochondrial retention by XIAP subsequent to mitochondrial outer membrane permeabilization.
    Flanagan L; Sebastia J; Delgado ME; Lennon JC; Rehm M
    Biochim Biophys Acta; 2011 May; 1813(5):819-26. PubMed ID: 21354220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain.
    Liu Z; Sun C; Olejniczak ET; Meadows RP; Betz SF; Oost T; Herrmann J; Wu JC; Fesik SW
    Nature; 2000 Dec 21-28; 408(6815):1004-8. PubMed ID: 11140637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101.
    Hu W; Wang F; Tang J; Liu X; Yuan Z; Nie C; Wei Y
    J Biol Chem; 2012 Jan; 287(1):68-80. PubMed ID: 22052903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.